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Abstract
Background: It is well established that some irradiated liver non-parenchymal cells secrete pro-inflammatory
cytokines to facilitate the development of radiation-induced liver disease. However, little is known on whether the
irradiated hepatoma cells-mediated non-irradiated hepatocyte injury occurs in HCC patients. Here, we elucidated
the roles of the irradiated hepatoma cells in driving non-irradiated hepatocyte injury and its underlying mechanism.
Methods: SMMC7721 cells were cultured and divided into irradiated (4-Gy X-ray, R) and non-irradiated (NR) groups.
At 24th hour after irradiation, conditioned medium (CM) from these cultures was mixed with normal culture
medium in specific proportions, and termed as 7721-R-CM and 7721-NR-CM. Following incubation with these CM
compound, the biological characteristics of L02 cells related to liver cell injury including viability, apoptosis and liver
dysfunction indices were comparatively analyzed. Simultaneously, the levels of proliferation- and apoptosis-related
cytokines in irradiated and non-irradiated SMMC7721 cells were also measured. FasL as a cytokine with significantly
differential expression, was selected to clarify its effects on L02 apoptosis. Subsequently, FasL expression following
irradiation was examined in SMMC7721 and other HCC cells with varying malignant potentials, as well as in HCC
tissues, the related mechanism of higher expression of FasL in irradiated HCC cells was further investigated.
Results: Apoptosis and liver dysfunction indices were all significantly enhanced in L02 cells treated with 7721-R-CM,
whereas viability was suppressed, compared to those with 7721-NR-CM stimulation. FasL was identified as a leading
differential cytokine in the irradiated SMMC7721 cells. Higher proportion of apoptosis was also found in L02 cells
following FasL incubation. A recombinant Fas-Fc protein, which blocks Fas-FasL interaction, ameliorated 7721-R-CM-
induced apoptosis in L02 cells. FasL was highly expressed in a dose-dependent manner, and peaked at the 24th
hour post-irradiation in different HCC cells and their culture supernatant. Meanwhile, phosphorylation levels of JNK,
ERK, Akt, and p38 were all upregulated significantly in irradiated HCC cells. But, only JNK inhibition was validated to
block radiation-induced FasL expression in HCC cells. c-Jun, the target transcription factor of JNK, was also activated.
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Conclusion: In HCC cells, the JNK-c-Jun pathway plays an important role in mediating irradiation- induced FasL
expression, which may be critical in determining non-irradiated hepatocyte injury.
Keywords: Hepatocellular carcinoma, Irradiation, JNK-c-Jun, FasL, Paracrine, Hepatocyte injury
Background
Hepatocellular carcinoma (HCC) is a common cancer in
China associated with poor prognosis. Following the initial
observation that HCC is radiosensitive tumor and with sub-
sequent developments in radiation technology, radiotherapy
(RT) has become a feasible and promising treatment mo-
dality for each stage of the disease, and is currently one of
the major methods used for palliative treatment of HCC.
However, delayed liver damage, such as radiation-induced
liver disease (RILD), characterized by early veno-occlusive
disease (2 weeks to 4 months after RT), late onset of apop-
tosis and necrosis of hepatocytes, liver dysfunction, radi-
ation fibrosis, is inevitable and sometimes lethal [1].
Therefore, finding a way to prevent both acute and late tox-
icity in liver injuries is of paramount importance.
The liver is a highly radiosensitive organ, and the
threshold dose for whole-liver irradiation is reportedly be-
tween 20 and 30 Gy [2]. Given that hepatocytes are more
radio-resistant than other cells [3], they are not the direct
and initial target during radiation-induced liver injury. Al-
though hepatic cell apoptosis resulting from radiation
contributes to liver injury, research targeting on liver cells
alone may not enable insight into all of the diverse patho-
logical changes occurring in RILD. Which cell initiates the
apoptotic signal, and what signaling pathways involve in
RILD, are still largely unknown.
Growing evidences suggest that RILD involves a com-
plex cascade of signal events between liver cells and the
host stromal microenvironment. This crosstalk modu-
lates or determines the occurrence and progression of
RILD. Generally, the microenvironment of liver cells in
HCC is composed of hepatoma cells, hepatic stellate
cells, fibroblasts, invading inflammatory/immune cells,
endothelial cells, and other non-cellular components
such as growth factors, inflammatory cytokines etc. [4].
The important roles of stromal cells and inflammatory
cytokines in RILD progression have been well docu-
mented in some literatures. Activated Kupffer cells pro-
duce and release numerous pro-inflammatory cytokines,
which initiate the acute hepatic microvascular pathogen-
esis that leads to apoptosis of the hepatocytes [5]. Condi-
tioned medium (CM) from irradiated Kupffer cells more
strongly induces apoptosis of irradiated hepatocytes than
normal medium because the CM contains higher levels
of TNF-α [6]. Moreover, inflammation cytokines also
participate in the development of RILD. TNF-α, IL-1,
and IL-6, are mediators of the pathogenesis in the early
phase of RILD [7]. Early veno-occlusive disease (VOD)
after radiation is a distinguishing characteristic of RILD,
and sinusoidal endothelial cell (SEC) injury has been trad-
itionally postulated as the initiating lesion of VOD in
RILD [8]. The number of apoptotic SECs increased signifi-
cantly after 30 Gy of liver irradiation in a rat model, by
contrast, apoptotic hepatocytes were only occasionally
seen [9]. SEC injury results in microcirculatory blood flow
disturbance and secondary injury to hepatocytes, causing
liver dysfunction. Thereby, early activation of stroma cells
and release of inflammatory cytokines may contribute to
radiation-induced liver injury. However, little studies are
carried out on the roles of hepatoma cells in the occur-
rence of RILD following HCC radiotherapy. The stress as
radiation, chemotherapy and heat shock enhance the
expression and secretion of cytokines in HCC cells
including interleukins (ILs), interferons (IFNs), TNFs,
colony-stimulating factors, growth factors and chemo-
kines [10–13]. Here, we hypothesized that the irradi-
ated hepatoma cells may release specific cytokines
and contribute to the occurrence of RILD.
In the present study, we found that the irradiated hepa-
toma cells promoted the apoptosis of normal hepatocytes
through the secretion of pro-apoptotic cytokines, among
which, a significant difference was seen in the expression
of FasL. Furthermore, we elucidated the molecular mech-
anism of irradiation-induced FasL expression in hepatoma
cells. From a perspective view of the interactions between
the irradiated HCC cells and normal hepatic cells, this
study provides novel insights into the pathogenesis of
radiation-induced liver injury in HCC patients.
Methods
Hepatoma cell and liver cell
MHCC97H and HCCLM3 cells, which have high malig-
nant potential, were established at the Liver Cancer
Institute of Fudan University [14]. Huh7 cells with low ma-
lignant potential were obtained from the Chinese Academy
of Sciences (Shanghai, China). Hep3B and SMMC7721 cells
with low malignant potential and the normal liver cells L02
were purchased from the American Type Culture
Collection (ATCC) (Manassas, VA, USA). These hepatoma
cells and liver cells were routinely maintained.
Chemical reagents and kits
Alanine transaminase (ALT), aspartate transaminase (AST),
albumin (ALB), malondi- aldehyde (MDA), and superoxide
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dismutase (SOD) kits were from the Nanjing Jiancheng Bio-
engineering Institute (Nanjing, China). SB203580, PD98059,
LY294002 and SP600125 were obtained from Sigma (St
Louis, MO, USA). Recombinant human soluble FasL and
Fas-Fc protein (which inhibits FasL activity) were purchased
from Alexis Corp. (San Diego, CA, USA).
Patients
Two independent cohorts with a total of 50 HCC patients
were enrolled in this study as previously described [15]. In
one cohort, after about 2 months of liver radiotherapy, 22
liver cancer patients underwent hepatectomy between
January 2005 and May 2013. None of the patients received
chemotherapy during the period of surrounding pre-
hepatectomy liver radiotherapy. In another cohort, 28
tumor tissue samples were consecutively collected from
patients undergoing curative resection between January
and October of 2010. All hepatectomies were performed
at the Liver Cancer Institute, Zhongshan Hospital, Fudan
University. Approval for this study was obtained from the
Zhongshan Hospital Research Ethics Committee.
Radiation
Cells were irradiated as described previously [16]. A dose
of 2–8 Gy X-ray irradiation was delivered to cells in a sin-
gle fraction, using a linear accelerator (Oncor; Siemens,
Munich, Germany). When hepatoma cells grew and
reached approximately 75 % confluency in a T75 flask, the
flask was placed on the couch, and a 1.5-cm-thick bolus
was used to correct the distribution of radiation. Irradi-
ation parameters were as follows: beam energy, 6-MV
photons; dose-rate, 3 Gy/min; source-surface distance,
100 cm; size of the radiation field, 20 × 20 cm2; gantry,
180°. Dosimetry was measured with a cylindrical
ionization chamber prior to irradiation.
Collection of conditioned medium
Hepatoma cells were exposed to X-ray firstly, then cells
were washed thoroughly and cultured in serum-free low-
glucose Dulbecco’s modified Eagle medium (DMEM) for
24 h, and their culture supernatant was collected. The
same medium was incubated for 24 h in a T75 flask with
non-irradiated liver cancer cells to serve as the control.
The collected culture medium was centrifuged at 4500 g
for 30 min at 4 °C. The supernatant was stored at −80 °C
for further use. The protein concentration of the CM was
measured by a bicinchoninic acid protein assay (Pierce,
Rockford, IL, USA).
Cell viability assay
About 200 μl of L02 cells (3 × 103cells) in DMEM con-
taining 10 % FBS were seeded into a 96-well plate. At
the indicated time points, 10 μl of CCK-8 solution
(Dojindo, Japan) was added to the cells and incubated
for 1 h. The number of viable cells in each well was
tested by absorbance at 450 nm.
Detection of apoptosis by FITC-labeled annexin V
Early apoptotic changes were detected by fluorescein
isothiocyanate (FITC)-Annexin V staining. Propidium
iodide (PI) was used to discriminate between apoptotic
and necrotic cells among the annexin-V-positive cells.
L02 cells (1 × 106) were washed then resuspended in
100 μl binding buffer solution (Annexin-V-FITC Kit,
Immunotech). Annexin V-FITC (5 μl) and PI (5 μl) were
then added to the cell suspension for a 10-min incubation
followed by fluorescence-activated cell sorting (FACS)
analysis. FACS files were analyzed using FlowJo version
9.5.2 (Tree Star, Ashland, OR). Gating strategies for apop-
totic cell are shown in Additional file 1: Figure S1.
Quantitative reverse transcription polymerase chain
reaction (qRT-PCR)
Total RNA extraction and qRT-PCR analysis were per-
formed as our previous work [17]. Relative gene expression
was normalized to glyceraldehyde phosphate dehydrogra-
nase (GAPDH) and reported as 2-ΔCt [ΔCt =Ct (FasL or
other genes)-Ct (GAPDH)]. The primer sequences of all de-
tected genes are listed in Table 1.
Table 1 Primer pairs used for qRT-PCR
Gene symbol Sequence 5′-3′
FasL Forward: 5′-TGCCTTGGTAGGATTGGGC- 3′
Reverse: 5′-GCTGGTAGACTCTCGGAGTTC - 3′
TRAIL Forward: 5′-TGCGTGCTGATCGTGATCTTC- 3′
Reverse: 5′-GCTCGTTGGTAAAGTACACGTA- 3′
TNF-α Forward: 5′-CCCGACTATCTCGACTTTGC- 3′
Reverse: 5′-GGTTGAGGGTGTCTGAAGGA- 3′
IL-6 Forward: 5′-CAATGAGGAGACTTGCCTGG- 3′
Reverse: 5′-GGCATTTGTGGTTGGGTCAG - 3′
IGF-1 Forward: 5′-GCTCTTCAGTTCGTGTGTGGA- 3′
Reverse: 5′-GCCTCCTTAGATCACAGCTCC - 3′
PDGFA Forward: 5′-GCAAGACCAGGACGGTCATTT- 3′
Reverse: 5′-GGCACTTGACACTGCTCGT- 3′
PDGFB Forward: 5′-CTCGATCCGCTCCTTTGATGA- 3′
Reverse: 5′-CGTTGGTGCGGTCTATGAG - 3′
VEGFA Forward: 5′-AGGGCAGAATCATCACGAAGT- 3′
Reverse: 5′-AGGGTCTCGATTGGATGGCA - 3′
TGF-β1 Forward: 5′-AGGACTGCGGATCTCTGTGT - 3′
Reverse: 5′-GGGCAAAGGAATAGTGCAGA - 3′
GAPDH Forward: 5′- CTCCTCCACCTTTGACGC - 3′
Reverse: 5′- CCACCACCCTGTTGCTGT- 3′
qRT-PCR quantitative real time reverse transcription polymerase chain reaction
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Western blot
Protein extraction and Western blot analysis were done as
previously described [18]. Primary antibodies were diluted
with 3 % TBSA as follows: ALB, Bcl-2, Bax, Bid, Fas, Akt, p-
Akt(Ser473), p-ERK (Thr202/Tyr204), ERK, p-p38(Thr180/
Tyr182), p38, caspase3, JNK, p-JNK(Thr183/Tyr185), c-
JUN, p-c-JUN (Ser73), or GAPDH (1:1000, Cell Signal
Technology, Danvers, MA), or FasL (1:500, Santa Cruz Bio-
technology, Santa Cruz, CA, USA). Secondary antibodies
were diluted with 3 % TBSA (against mouse and rabbit,
1:5000; Dingguo Bio, Beijing, China).
Immunohistochemistry analysis
Immunohistochemical staining was performed based on
the method of Wu [15]. In a typical procedure, after rehy-
dration and antigen retrieval, cell slides were incubated
with diluted primary antibodies against FasL (1:100, Santa
Cruz) at 4 °C overnight, followed by HRP-conjugated sec-
ondary antibody (anti-rabbit, 1:200; DingguoBio) at 37 °C
for 30 min. Finally, the slides were stained with 3,3′-di-
aminobenzidine (DAB) and counterstained with Mayer’s
hematoxylin. Staining intensity and the percentage of im-
munoreactive tissues were scored by two independent ob-
servers, who were blinded to the patients’ outcomes. Five
high-power fields (magnification, 200×) were randomly se-
lected. Based on the IHC staining percentage and intensity
of positive cells counted in each core, immunoreactivity
was categorized as follows: negative (−), weak or mild (+),
moderate (++), strong (+++), or stronger (++++), which
corresponding successively to 0–4 points. The level of
FasL expression in the two independent cohorts of HCC
patients were compared.
Immunofluorescence staining
Immunofluorescence staining was done as the method re-
ported previously [17]. FasL (1:25, Santa Cruz, USA) anti-
body was diluted in 1 % bovine serum albumin (BSA).
Secondary antibody was Alexa Fluor 488-conjugated goat
anti-mouse antibody (Molecular Probes, Eugene, OR).
Enzyme-linked immunosorbent assay (ELISA)
The level of FasL in cell culture supernatants was de-
termined using the Quantikine Human FasL ELISA Kit
(Abcam Systems) according to the manufacturer’s in-
structions. Briefly, 100 μL sample was added to each well
and incubated for 2.5 h at room temperature. The plates
were washed and incubated with the FasL conjugate for
2 h. After washing, immunoreactivity was determined by
adding substrate solution and the absorbance was deter-
mined using a Microplate Spectrophotometer (Bio-Rad,
Hercules, CA, USA). A curve of absorbance versus the
concentration of FasL in the standard wells was plotted.
Recombinant plasmid construction and transfection
To generate plasmid-expressing c-Jun-shRNA, double-
stranded oligonucleotides were cloned into GV248 vector.
The sequences of c-Jun-shRNA used are CcggcgGACCT-
TATGGCTACAGTAActcgag TTACTGTAGCCATAAGG
TCCGTTTTTg.
The uppercase letters represent c-Jun-specific se-
quence, and lowercase letters represent hairpin se-
quences. SMMC7721 and MHCC97H were transfected
with plasmid using lipofectamine 2000.
Statistical analysis
Data were analyzed using SPSS software (version 16.0).
Results were expressed as mean ± SD. Statistical analysis
was performed by one-way ANOVA and Student’s t
-test. P < 0.05 was considered statistically significant.
Results
CM derived from the irradiated HCC cells promoted
normal hepatocyte injury
CM derived from the irradiated SMMC7721 cells with
various dose irradiation (2, 4 and 6Gy) and CM from
non-irradiated SMMC7721 cells were collected. Liver
cells were treated with various concentrations of CM
compound (CM mixed with completed DMEM in ratios
of 1:4, 1:2, 1:1, 2:1, and 4:1) for 48 h. CCK8 assays
showed that CM compound from the irradiated
SMMC7721 cells reduced the viability of liver cells com-
pared with that from non-irradiated cells. The most ob-
vious difference occurred at the dose of 4Gy irradiation
and media proportion of 2:1 (Fig. 1a). The CM com-
pound from irradiated (4Gy) and non-irradiated
SMMC7721 cells at ration of 2:1 with completed DMEM
were termed as 7721-R-CM and 7721-NR-CM, respect-
ively. We further evaluated their effects on the viability
of liver cells. As shown in Fig. 1b, 7721-R-CM decreased
cell viability in a time-dependent manner compared with
7721-NR-CM, and the liver cells treated with 7721-R-CM
exhibited a reduction of about 20 % in viability (P < 0.01).
Cell apoptosis analysis showed that the proportion of
early apoptosis and late apoptosis in the treated L02 cells
(25.2 ± 5.82 %) with 7721-R-CM were remarkably in-
creased as compared with that of the control with 7721-
NR-CM (13.3 ± 2.53 %) (Fig. 1c, d). Simultaneously, expres-
sions of pro-apoptotic protein Bax, Bid and cleaved caspase
3, which act as key executors in apoptosis and play import-
ant roles in programmed cell death, were upregulated in
the treated L02 cells with 7721-R-CM, whereas the anti-
apoptotic Bcl-2 was decreased (Fig. 1e, Additional file 2:
Figure S2). Unprocessed and uncropped western blot pic-
tures were supplied in Additional file 3: Figure S3.
Levels of AST, ALT, ALB, SOD2, and MDA in culture
medium reflects the extent of live cell injury. As shown
in Fig. 1f, 7721–R-CM-treated liver cells exhibited a
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Fig. 1 (See legend on next page.)
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significant elevation in the activities of ALT, AST and a
depletion in ALB content. Meanwhile, the treated cell
also had a significant decline in SOD2 levels and an in-
crease in the concentration of MDA (Fig. 1f ).
These data mentioned above suggest that culture
medium from the irradiated HCC cells may contribute to
the injury of liver cells by suppressing hepatocyte viability
as well as inducing liver cell apoptosis and dysfunction.
FasL in CM from the irradiated HCC cells may enhance
liver cell injury
The development of CM-induced liver cell injury in vitro
indicates that irradiation might alter the production and
secretion of certain factors that result in obvious changes
in cell proliferation and apoptosis. Thereby, we compara-
tively analyzed gene expression levels of some known cy-
tokines related to cell growth (transforming growth factor
[TGF]-β1, vascular endothelial growth factor [VEGF] A,
insulin-like growth factor [IGF]-1, IL-6, platelet-derived
growth factor [PDGF] A, PDGFB) and death (FasL, TNF-
related apoptosis-inducing ligand [TRAIL], TNF-α) be-
tween in irradiated SMMC7721 cells and in non-
irradiated cells. Irradiation significantly upregulated the
mRNA expressions of FasL, TRAIL, TNF-α, and TGF-β1
in hepatoma cells, and downregulated the mRNA expres-
sions of IGF-1 and PDGFB (Fig. 2a), but no obvious effects
on the expressions of VEGFA, PDGFA, and IL-6. Among
these cytokines, FasL was identified as a leading differen-
tial expression cytokine in the irradiated HCC cells. We
further speculated that FasL in 7721-R-CM may play an
important role in the induction of liver cell injury. To con-
firm this notion, we pre-incubated L02 cells with 7721-R-
CM and 7721-NR-CM for 18 h, and subsequently treated
them with 50 ng/ml FasL for 6 h. As expected, FasL caused
a significant increase in L02 cell death and caspase3 activa-
tion, as compared to treatment with only 7721-R-CM or
7721-NR-CM for 24 h. Moreover, we employed a recom-
binant Fas-Fc protein to block the interaction between Fas
and FasL, and found that the inclusion of 1 μg /mL Fas-Fc
in the medium significant reduced the rate of liver cell
death and the expression of cleaved caspase3 compared
with the control (Fig. 1c, d, Additional file 2: Figure S2).
Simultaneously, Fas-Fc prevented 7721-R-CM-induced
changes of AST, ALT, ALB, SOD2 and MDA (Fig. 1f ). In
addition, 7721-R-CM incubation upregulated Fas (FasL
receptor) expression in L02 cells (Fig. 1e). These data
suggest that FasL, secreted from the irradiated hepa-
toma cells promotes the injury of liver cells.
Subsequently, five types of hepatoma cells with differ-
ent malignant potentials were used to validate changes
in FasL levels following radiation. Hepatoma cells
received a single dose of 0, 2, 4, 6, and 8 Gy radiation re-
spectively and further incubated for 24 h. Higher radi-
ation dose resulted in higher gene expression of FasL
(Fig. 2b). In addition, the up-regulation of FasL in the ir-
radiated hepatoma cells was independent of malignant
potential, and the sensitivity to radiation was also differ-
ent among different types of hepatoma cells.
MHCC97H cells and SMMC7721 cells with higher
and lower malignant potential were further explored
what occurred in the cell culture medium following ir-
radiation. Be consistent with the results of qRT-PCR,
FasL protein level also exhibited a dose- dependent man-
ner with irradiation dose at 0, 2, 4, 6, and 8 Gy, levels of
FasL were detectably higher at 12th hour after irradi-
ation and reached a maximum at 24th hour, but no sig-
nificant variations were observed between 12 and 48 h
(Fig. 2c). These data were confirmed by western blot,
in which a 39-kDa band corresponding to FasL pro-
tein was detectable in extracts from non-irradiated
and irradiated MHCC97H and SMMC7721 cells
(Fig. 3a,b). Unprocessed and uncropped western blot
pictures were provided in Additional file 4: Figure S4.
Confocal microscopy also supported that FasL expression
in the cell cytoplasm was induced by irradiation (Fig. 3c).
Two sets of HCC tissue samples were used to define the re-
lationship between radiation and FasL expression. FasL
expression in the radiation group was remarkably higher
than that in the non-radiation group (Fig. 4), indicating a
positive correlation between FasL expression and radiation.
Together, these data imply that radiotherapy may
modulate the expression of FasL in HCC cells, further
influence liver cell apoptosis.
Radiation elevates the level of FasL in HCC cells via
activating the JNK-c-Jun pathway
Radiation exposure is a kind of stress and may activate
several intracellular signaling pathways, such as mitogen-
(See figure on previous page.)
Fig. 1 Conditioned medium derived from the irradiated HCC cells enhanced normal hepatocyte injury. a Conditioned media were collected from
irradiated SMMC7721 cells (with exposure to 2, 4, or 6 Gray) and non-irradiated SMMC7721 cells after incubated for 24 h. Conditioned medium
from each of the four groups was mixed with normal medium in different proportion (1:4, 1:2, 1:1, 2:1, and 4:1). Normal hepatocytes L02 were
incubated with these mixtures for 48 h. The viability of L02 cells was examined by CCK8 assay. b Viability of L02 cells was examined by the CCK8
assay at different time points after incubation with 7721-NR-CM and 7721-R-CM. Data presented were fold-change of 7721-R-CM group compared
with 7721-NR-CM group ± SD from three independent experiments. **P < 0.01. c, d L02 cells were cultured in different medium as indicated, and
apoptotic cells were detected by flow cytometry after 24 h. e The protein levels of Fas, ALB, Bcl-2, Bid, Bax, and cleaved caspase3 were determined by Western
Blot. GAPDH was used as a loading control. f Changes of AST, ALT, ALB, SOD2, and MDA levels in culture supernatant of L02 cells after
incubated with 7721-R-CM and 7721-NR-CM alone or combined with Fas-Fc. *P < 0.05, **P < 0.01
Dong et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:114 Page 6 of 12
activated protein kinase (MAPK) and phosphoinositol-3-
kinase (PI3K) [19]. Here, we investigated the effects of
radiation on activation of downstream molecules of MAPK
and PI3K pathways including p38, extracellular signal-
regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK)
and Akt. A dose of 4Gy radiation could promote p38, ERK,
JNK, and Akt phosphorylation in SMMC7721 cells, but no
effects on expression of p38, ERK, JNK, and Akt (Fig. 5a),
indicating that all of signal molecules were activated.
We respectively used SB203580, PD98059, LY294002,
and SP600125 to inhibit phosphorylation of p38, ERK,
Akt, and JNK, and found that only JNK-specific inhibitor
SP600125 suppress radiation-induced FasL expression in
SMMC7721 cells (Fig. 5a, b). This finding suggests that
radiation may activate MAPK and its downstream kinase
JNK, and contribute to radiation-induced FasL expression.
The c-Jun transcription factor is an important and spe-
cific target for JNK [20], therefore, we further analyzed the
effect of radiation (4Gy) on the activation of c-Jun. Indeed,
we observed phosphorylation of c-Jun, which could be
blocked by the inhibitor of JNK. Consistent with the obser-
vations in SMMC7721 cells, activation of JNK-c-Jun signal-
ing pathway also participated in radiation-induced FasL
expression in MHCC97H cells (Fig. 5b). Additionally, the
alteration of FasL levels in culture medium was similar to
the changes in HCC cells (Fig. 5c). In order to confirm the
effect of c-Jun on FasL expression, we transfected shRNA-
c-Jun intoSMMC7721 and MHCC97H cells. As shown in
Fig. 2 Irradiation altered the expressions of some proliferation and apoptosis- associated cytokines in SMMC7721 cells. a 24 h after irradiation,
expressions of nine proliferation- and apoptosis- associated cytokines were examined using RT-PCR.*P < 0.05, **P < 0.01, ***P < 0.001. b Effect of
radiation on FasL expression in human hepatoma cells with different malignant potentials was explored. Five types of hepatoma cells indicated
were treated with single doses of 0-8Gy respectively, and incubated for 24 h. The expressions of FasL in five hepatoma cells were measured by
RT-PCR. c SMMC7721 cells and MHCC97H cells, representing low and high malignant potential, as indicated, were treated with single doses of
0–8Gy, and incubated for 12, 24, and 48 h respectively, then the concentration of the secreted FasL in culture medium was measured by ELISA
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Fig. 3 Irradiation upregulated FasL expression in SMMC7721 cells and MHCC97H cells. a Protein levels of FasL in HCC cells were determined after
be irradiated with doses of 0, 2, 4, 6, 8Gy and incubated for 24 h. b FasL expression was detected in HCC cells after be irradiated with 4 Gy and
incubated for 12, 24, and 48 h, respectively, by Western Blot. GAPDH was used as a loading control. c Increased expression of FasL was confirmed
by immunofluorescent staining inHCC cells after be irradiated with 4Gy and incubated for 24 h
Fig. 4 Effect of radiotherapy on FasL expression in HCC tissues. Representative images of FasL staining in HCC tissues with radiotherapy and
without radiotherapy. FasL expression was analyzed by immunohistochemistry. Five randomly selected areas were viewed by light microscopy
(200× total magnification). Data on the staining scores are shown as means ± SD. * *P < 0.01
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Fig. 5d, FasL expression was decreased significantly in hepa-
toma cells with lower c-Jun expression. Unprocessed west-
ern blot pictures of Fig. 5a, b, d were supplied in Additional
files 5 and 6: Figures S5 and S6. All above data suggest that
radiation upregulates FasL expression in hepatoma cells
through activating the JNK-c-Jun signaling pathway.
Discussion
Results of the present study indicate that irradiated HCC
cells and their surrounding non-irradiated liver cells could
exhibit crosstalks, which results in a significant increase in
hepatocyte injury. Liver cell injury was mainly evaluated
by means of hepatocyte apoptosis and liver cell function.
Fig. 5 JNK-c-Jun signal pathway may contributes to radiation-enhanced FasL expression. a SMMC7721 cells were treated with chemical inhibitors,
SB203580 (p38), PD98059 (MAPK/ERK), LY294002 (PI3K/Akt), and SP600125 (SAPK/JNK) respectively for 60 min before irradiation. FasL and phos-
phorylated forms of p38, Akt, ERK, JNK in HCC cells were analyzed after be irradiated with 4Gy exposure and incubated for 24 h. b Activation of
the JNK-c-Jun signaling pathway was investigated by Western Blot. c The protein levels of FasL in culture supernatant were determined using
ELISA. d FasL expression after c-Jun silencing. *P < 0.05
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Apoptosis, as one of the terminal pathways of the cell
cycle, is a typical form of programmed cell death. It occurs
in morphogenesis during embryonic development and in
the elimination of aged or harmful cells for adult tissue
homeostasis maintenance [21]. Apoptosis of hepatic cells
is considered to be a prominent pathological feature in
most forms of liver injury such as chronic viral hepatitis,
cholestatic liver disease, and acetaminophen-induced hep-
atotoxicity [22], it is also a feature of irradiated hepatoma
cell-induced non-irradiated liver cell injury. Cytokines,
death ligands trigger caspase activation and induce cell
apoptosis [23]. TNF-α and FasL-induced mouse hepatitis
models exhibit activation of effector caspase-3 [24]. Bax,
Bid and Bcl-2 are also associated with apoptosis pathways.
Bax and Bid induce alterations in the mitochondrial per-
meability barrier by inserting into the mitochondrial
membrane and driving the release of caspase-activating
proteins from these organelles, like cytochrome c [25].
Bcl-2 can prevent induction of apoptosis caused by a wide
variety of stimuli including cytotoxic cytokines, gamma ir-
radiation, and chemotherapeutic drugs [26]. Bcl-2 controls
a late event in a final common pathway during pro-
grammed and apoptotic cell death [27]. Several factors
could reduce Bcl-2 levels and elevate Bax levels to induce
cell apoptosis [28]. Our data demonstrated that 7721-R-
CM promoted L02 apoptosis, upregulated the expressions
of cleaved caspase-3, Bax and Bid, whereas suppressed
the expression of Bcl-2, implying that some secreted
cytokines in 7721-R-CM may drive or induce the oc-
currence of apoptosis of liver cells. On the other
hand, 7721-R-CM also resulted in higher activities of
AST, ALT and decrease of ALB expression in culture
media of hepatocytes, which indicate a severe injury
of liver cell function. Superoxide dismutase 2 (SOD2)
is essential in detoxifying superoxides generated in
the mitochondrial matrix and protecting mitochondria
from reactive oxygen species (ROS), and is sensitive
to liver injury [29]. As expected, 7721-R-CM down-
regulated the expression of SOD2 and increased the
level of MDA in the supernatant of hepatocytes, sug-
gesting that an increase of lipid peroxidation leading
to cell damage, and the failure of antioxidant defense
mechanisms [30]. Thereby, the treated liver cells
with 7721-R-CM can better mirror the changes of
liver injury, and there exists a positive correlation be-
tween the extent of caspase activation and the grade
of liver injury.
In general, the death receptor-dependent (extrinsic)
pathway and the mitochondrial-dependent (intrinsic)
pathway are all involved in the regulation of cell apop-
tosis [22], and HCC cells also express diverse biological
factors with pro- or anti-apoptotic activities [31]. Here,
we also mentioned that the most obvious difference in
liver cell viability occurred at the dose of 4Gy irradiation
and media proportion of 2:1, but not at 6 Gy and 4:1
(Fig. 1a). This result indicates that radiation not only en-
hances pro-apoptotic factors level, but also upregulates
proliferation factors like TGFβ1 (Fig. 2a). Other study
also shows that radiation induces proliferation factor
VEGF-C expression in lung cancer [32]. These secreted
cytokines with different function influence cell prolifera-
tion or apoptosis together in conditioned medium from
irradiated hepatoma cells. Taken together, the secreted
cytokines from irradiated hepatoma cells may alter the
microenvironment of the hepatocytes, and cause injury
of the non-irradiated liver cells.
FasL was identified in this study as a leading differential
cytokine between in the irradiated hepatoma cells and in
non-irradiated cells. It is a transmembrane type II protein
belonging to the TNF protein superfamily, which is also
an important member of the death receptor-mediated ex-
trinsic pathways [33]. Radiation increases FasL expression
in many tumor types such as lymphoma, breast cancer,
liver cancer and nasopharyngeal carcinoma [34–37]. So,
we speculated that irradiated liver cancer cells could ex-
press FasL and mediate apoptosis of non-irradiated liver
cells. Our data showed that FasL enhanced the apoptosis
of L02 cells, and the Fas-Fc protein, which inhibits FasL-
Fas interactions, ameliorated cell apoptosis, suggesting
that FasL may play an important role in the apoptotic ef-
fect of irradiated hepatoma cells on normal hepatocytes.
These results were consistent with those of other studies
[38], supporting that FasL/Fas signaling pathway stimu-
lates apoptosis in liver cells.
In this study, radiation increased FasL expression in a
dosedependent manner, and activated PI3K/Akt, MAPK/
ERK, JNK, and p38, but only inhibition of JNK decreased
the expression of FasL in hepatoma cells, indicating that
radiation may upregulate the expression of FasL via JNK
signaling pathway. The results were in agreement with
other studies. Ectopic expression of MEKK1, regulated
by the JNK pathway, leads to apoptosis and FasL expres-
sion in Jurkat T cells [20]. Upon cisplatin treatment, sus-
taining activation of JNK and p38 kinase (p38K)
promotes upregulation of FasL in TR-4 cells [39]. JNK
are key mediators of stress signals and seem to be re-
sponsible for protective responses, stress-dependent
apoptosis, and inflammatory responses [40]. Various
stresses such as UV and γ-irradiation, osmotic stress,
and heatshock, as well as by pro-inflammatory cytokines
(tumor necrosis factor-α, interleukin-1) and chemothera-
peutic drugs can stimulate JNK signaling pathway [41].
Several transcription factors, such as c-Myc, nuclear fac-
tor (NF)-kB, and activating protein (AP)-1, are involved
in regulation of FasL expression. UV irradiation upregu-
lated FasL expression through NF-kB and AP-1 activa-
tion in Jurkat T cells [42]. Heterodimeric AP-1 complex
consists of c-Jun and activating transcription factor 2
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(ATF2) [43]. Similar with these reports, c-Jun activation
in irradiated hepatoma cells also played important roles
in enhancing FasL expression. Hereby, JNK-c-Jun signal-
ing pathway may contribute higher expression of FasL in
hepatoma cells exposed to X-ray irradiation.
Conclusions
In summary, this study constitutes the first observation
that several secreted factors from irradiated HCC cells dir-
ectly trigger apoptosis in liver cells. The data strongly sug-
gest an involvement of JNK-c-Jun signaling pathway in
irradiation-induced higher expression of FasL in hepatoma
cells, and its roles in radiation-induced liver injury. Our
study proposes a new paradigm (Fig. 6) that radiotherapy-
induced FasL could be a paracrine apoptotic stimulus to
accelerate radiation-induced liver injury.
Additional files
Additional file 1: Figure S1. FACS gating strategy of Annexin V/PI
staining. (a) AnnexinV/PI staining was presented for population after gating
by forward/side scattering. (b) Negative control, which is unstained sample
to decide cutoff line for negative cells. The combination of Annexin V-FITC
and propidium iodide (PI) allows for the distinction between early apoptotic
cells (Annexin V-FITC positive), late apoptotic and/or necrotic cells (Annexin
V-FITC and PI positive), and viable cells (unstained). (c) Liver cells were
detected according to the cutoff line for negative cells to identify early
apoptotic cells, late apoptotic and/or necrotic cells and viable cells.
(JPG 349 kb)
Additional file 2: Figure S2. Changes of caspase-3 activation in L02
cells after different treatment. L02 cells were cultured in different medium
as indicated, and cleaved caspase3 were detected by flow cytometry after
24 h. (a) Data shown are representative histograms from each group of
cells for three separate experiments. (b) The percentage of positive cells
was indicated. (JPG 149 kb)
Additional file 3: Figure S3. Uncropped and unprocessed immunoblot
pictures of Fig. 1E. (JPG 101 kb)
Additional file 4: Figure S4. Uncropped and unprocessed immunoblot
pictures of Fig. 3A, B. (JPG 556 kb)
Additional file 5: Figure S5. Uncropped and unprocessed immunoblot
pictures of Fig. 5A, D. (JPG 1202 kb)
Additional file 6: Figure S6. Uncropped and unprocessed immunoblot
pictures of Fig. 5B. (JPG 613 kb)
Abbreviations
ALB, albumin; ALT, alanine transaminase; AP-1, activating protein 1; AST aspartate
transaminase; ATF, activating transcription factor; BSA, bovine serum
albumin; CM, conditioned medium; ELISA, enzyme-linked immunosorbent
assay; ERK, extracellular signal-related kinase; FACS, fluorescence-activated
cell sorting; FITC, fluorescein isothiocyanate; GAPDH, glyceraldehyde phosphate
dehydrogenase; HCC, hepatocellular carcinoma; IFN, interferon; IGF, insulin-like
growth factor; IL, interleukin; JNK, c-Jun N-terminal kinase; MAPK, mitogen-
activated protein kinase; MDA, malondialdehyde; NF-kB, nuclear factor kappa B;
PBS, phosphate-buffered saline; PDGF, platelet-derived growth factor; PI,
propidium iodide; PI3K, phosphoinositol-3-kinase; qRT-PCR, quantitative reverse
transcription polymerase chain reaction; RILD, radiation-induced liver disease;
ROS, reactive oxygen species; SEC, sinusoidal endothelial cell; SOD, superoxide
dismutase; TBSA, the mixture formed by dissolving BSA with TBST to the
required concentration; TGF, transforming growth factor; TNF-α, tumor necrosis
factor; TRAIL, TNF-related apoptosis-inducing ligand; VEGF, vascular endothelial
growth factor; VOD, veno-occlusive disease.
Funding
This work was supported by the Specialized Research Fund for the Doctoral
Program of Higher Education of China (20120071110065).
Authors’ contributions
ZCZ and JFC conceived and designed the study, YYD, XYS, MYH, ZFW, YHW,
QDZ performed the experiments and analyzed the data, YYD, XYS and MYH
wrote the manuscript. YHC, SFW contributed statistical analysis. All authors
read and approved the final manuscript.
Competing interests
The authors declared that they have no competing interests.
Author details
1Department of Radiation Oncology, Zhongshan Hospital, Fudan University,
180 Feng Lin Road, Shanghai 200032, People’s Republic of China. 2Liver
Cancer Institute, Zhongshan Hospital, Fudan University & Key Laboratory of
Carcinogenesis and Cancer Invasion, Ministry of Education, 180 Feng Lin
Road, Shanghai 200032, People’s Republic of China. 3Department of
Radiology, Shanghai Cancer Center, Fudan University, Shanghai 200032,
People’s Republic of China.
Fig. 6 Schematic of mechanism. Diagram of the proposed mechanism by which irradiation initiates the JNK-c-Jun pathway to upregulate FasL expression
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